UNSPSC 85613343: Bypass accessory pancreatic duct to large intestine, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass accessory pancreatic duct to large intestine, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0F1F4ZC

UNSPSC 85613343 Bypass accessory pancreatic duct to large intestine, percutaneous endoscopic approach is a Commodity code with minimal relevance to state and local procurement activity. The code describes a specific surgical procedure and does not align with the work actually being solicited by state and local issuing bodies in recent opportunities. Recent state and local solicitations posted under or near this code taxonomy span occupational health surveillance, pharmacy benefit management, temporary health professional staffing, disability medical evaluations, specialty surgical carve-outs, and juvenile detention medical services—none of which correspond to the procedural code's nominal scope. State and local procurement systems occasionally assign medical procedure codes to broader healthcare administration and staffing services through classification variance or data entry misalignment; this code exhibits that mismatch.

The recent opportunities show activity across Arizona, California, Florida, and Washington, issued by municipal retirement offices, county health systems, county commissioners' procurement divisions, and state transportation departments. Representative solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026), the County of Santa Clara Health System's RFQ for temporary health professional staffing (due October 7, 2026), and the Washington State Department of Transportation's RFP for occupational medical surveillance (due October 9, 2026, with pre-bid conference August 31, 2026). The code shows limited genuine activity under its stated procedural definition and should not be pursued as a primary procurement category for medical device, implant, or surgical service suppliers.